Pfizer's COVID-19 vaccine, known as Comirnaty, was developed in collaboration with BioNTech. This mRNA vaccine is protected under several patent filings related to mRNA technology, including a broad patent landscape covering aspects such as delivery methods and formulations. One of the main patents associated with this vaccine is WO2021213945A1, which relates to the mRNA vaccine technology used to combat SARS-CoV-2. The patent covers innovations around the use of mRNA to encode specific viral proteins that trigger an immune response against COVID-19
FDA.This vaccine also went through a series of approvals, including post-marketing studies and additional safety assessments, particularly concerning myocarditis and pericarditis risks
If you're interested in exploring the patent details further, they are available through the World Intellectual Property Organization (WIPO) database and other patent resources.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.